Index Entries - Covid Index

1616 Results

Title	IS Publication Date
Patient Betrayal: The Corruption of Healthcare, Informed Consent and the Physician-Patient Relationship	March 1, 2022
Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective observational study	October 26, 2017
People's COVID-19 Vaccine Inquiry: Witness statement of Dr. Elizabeth Evans, on behalf of the UK Medical Freedom Alliance	April 10, 2024
Perceived Experience in Social Circles with COVID-19 Injections and COVID-19 “Vaccine” Mandates: An Online Survey of the United States Population	February 16, 2024
Periodic Safety Update Report #3 (Pfizer)
Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans	September 27, 2021
Persistence of S1 Spike Protein in CD16+ Monocytes up to 245 Days in SARS-CoV-2 Negative Post COVID-19 Vaccination Individuals with Post-Acute Sequalae of COVID-19 (PASC)-Like Symptoms	March 24, 2024
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection	January 10, 2022
Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19	November 29, 2024
Persistent Nonviral Plasmid Vector in Nasal Tissues Causes False-Positive SARS-CoV-2 Diagnostic Nucleic Acid Tests	October 13, 2022
Persistent varicella zoster virus infection following mRNA COVID-19 vaccination was associated with the presence of encoded spike protein in the lesion	August 25, 2022
Perspective: Universal Masking in Hospitals in the Covid-19 Era	May 21, 2020
Pfizer 16+ Documents	November 17, 2021 - November 1, 2023
Pfizer clinical trial: Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study	First posted April 19, 2021; last updated June 27, 2023
Pfizer Corporate Rap Sheet	Last updated February 3, 2017
Pfizer director admits vaccine was never tested on preventing transmission	October 11, 2022
Pfizer DNA Detected in Colon Cancer Biopsy: Kevin McKernan Presents Findings	October 19, 2024
Pfizer Medical, Scientific & Patient Education Grant Transparency
Pfizer trial paper: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine	December 10, 2020
Pfizer/BioNTech’s COVID-19 modRNA Vaccines: Dangerous Genetic Mechanism of Action Released before Sufficient Preclinical Testing	Winter 2024
Pharmaceutical product recall and educated hesitancy towards new drugs and novel vaccines	November 6, 2024
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults by AstraZeneca	updated April 7, 2023
Physicians Declaration – Global COVID Summit, Rome, Italy	September 2021
Physicians Declaration II	October 29, 2021
Pilot study on burden of fungal contamination in face masks: need for better mask hygiene in the COVID-19 era	November 20, 2021
Plaintiffs Motion for Preliminary Injunction: America’s Frontline Doctors, et al., vs. Xavier Becerra, Secretary of the US Department of Health and Human Services	July 19, 2021
Plan B Public Health Infrastructure and Operations Oversight Reform for America	January 5, 2021
Plastic waste release caused by COVID-19 and its fate in the global ocean	November 8, 2021
Pneumonia and Influenza Mortality Surveillance from the National Center for Health Statistics Mortality Surveillance System
Poll: Majority of Democrats say the unvaccinated should be confined to home	January 25, 2022
Population - With a Disability, 16 Years and over	August 4, 2023
Portal Vein Thrombosis Might Develop by COVID-19 Infection or Vaccination: A Systematic Review of Case-Report Studies	December 14, 2021
Position Paper – COVID-19 Vaccine for Children	November 24, 2021
Position Paper: The Science and the Ethics Regarding the Risk Posed by Non-Vaccinated Individuals	August 11, 2021
Position paper: Use of facemasks in the community as a means to curb the spread of the COVID-19 virus	March 31, 2022
Position Statement on COVID-19 Vaccines for Children	May 8, 2024
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study	June 24, 2021
Possible toxicity of chronic carbon dioxide exposure associated with face mask use, particularly in pregnant women, children and adolescents – A scoping review	March 2, 2023
Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients	October 11, 2021
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study	July 28, 2022
Postmortem investigation of fatalities following vaccination with COVID-19 vaccines	September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition	October 5, 2021
Potential adverse effects of nanoparticles on the reproductive system	December 11, 2018
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)	May 31, 2021
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial	June 24, 2021
Potential Conscientious Objection to mRNA Technology as Preventive Treatment for COVID-19	August 23, 2022
Potential health risks of mRNA-based vaccine therapy: A hypothesis	January 25, 2023
Potential Links Between the Wuhan Institute of Virology and the Origin of the COVID-19 Pandemic	June 2023
Potential toxicity of nanoparticles on the reproductive system animal models	September 25, 2021
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children	August 18, 2021

Page 21 of 33